Literature DB >> 21913997

Association of polymorphisms in genes encoding IL-4, IL-13 and their receptors with atopic dermatitis in a Korean population.

Jung-Hyun Namkung1, Jong-Eun Lee, Eugene Kim, Hyun-Je Kim, Eun-Young Seo, Hye-Yoon Jang, Eun-Soon Shin, Eun-Young Cho, Jun-Mo Yang.   

Abstract

Th2-dominated immune responses are believed to contribute to the pathogenesis of atopic dermatitis (AD). IL-4 and IL-13 are typical pleiotropic Th2 cytokines that play a central role in IgE-dependent inflammatory reactions. Single-nucleotide polymorphisms (SNPs) in IL-4 and IL-13 have been reported in patients with allergic disease from numerous countries. Gene-gene interactions among genes have been identified in patients with asthma, although negative results have been reported. To investigate the associations of SNPs in these genes and the interactions between these genes in AD, we genotyped 23 SNPs of the IL-4, IL-13, IL-4R, IL-13Rα1 and IL-13Rα2 genes for 1089 case-control samples (631 AD patients and 458 controls) and analysed the SNPs and haplotypes in these genes. We also searched for gene-gene interactions among these five genes. Our data identified an association between rs3091307 and rs20541 in the IL-13 gene and between rs2265753 and rs2254672 in the IL-13Rα1 gene and the AD phenotype. In particular, three of the four SNPs were especially predictive of the allergic type of AD (ADe), and the haplotype TCGG in the IL-13Rα1 gene showed significant association with AD, especially ADe. Furthermore, the combination of rs3091307 GG/ rs2265753 GG (IL-13/IL-13Rα1) conveyed a significantly higher risk for developing ADe. However, we did not identify any SNPs in the IL-4, IL-4R and IL-13Rα2 genes that were associated with AD. As IL-13Rα1 is most likely expressed in Th17 cells rather than in Th2 cells, these data suggest diversity in the classification of Th cells that needs to be verified in future studies.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21913997     DOI: 10.1111/j.1600-0625.2011.01357.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  21 in total

1.  Pathophysiology of atopic dermatitis: Clinical implications.

Authors:  Jihyun Kim; Byung Eui Kim; Donald Y M Leung
Journal:  Allergy Asthma Proc       Date:  2019-03-01       Impact factor: 2.587

Review 2.  Molecular biology of atopic dermatitis.

Authors:  Zhanglei Mu; Yan Zhao; Xiaojing Liu; Christopher Chang; Jianzhong Zhang
Journal:  Clin Rev Allergy Immunol       Date:  2014-10       Impact factor: 8.667

Review 3.  The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies.

Authors:  Patrick M Brunner; Emma Guttman-Yassky; Donald Y M Leung
Journal:  J Allergy Clin Immunol       Date:  2017-04       Impact factor: 10.793

Review 4.  The Genetics and Epigenetics of Atopic Dermatitis-Filaggrin and Other Polymorphisms.

Authors:  Yunsheng Liang; Christopher Chang; Qianjin Lu
Journal:  Clin Rev Allergy Immunol       Date:  2016-12       Impact factor: 8.667

5.  Association between severe eczema in children and multiple comorbid conditions and increased healthcare utilization.

Authors:  Jonathan I Silverberg; Eric L Simpson
Journal:  Pediatr Allergy Immunol       Date:  2013-06-16       Impact factor: 6.377

6.  Neonatal capsaicin treatment in rats induces chronic hyperthermia resulting in infectious disease.

Authors:  Keun-Yeong Jeong; Hwan Mook Kim
Journal:  Exp Ther Med       Date:  2015-10-23       Impact factor: 2.447

7.  Are Podoplanin Gene Polymorphisms Associated with Atopic Dermatitis in Koreans?

Authors:  Jung-Hyun Namkung; Eugene Kim; Yong-Doo Park; Geontae Park; Jun-Mo Yang
Journal:  Ann Dermatol       Date:  2015-05-29       Impact factor: 1.444

8.  Additive effect between IL-13 polymorphism and cesarean section delivery/prenatal antibiotics use on atopic dermatitis: a birth cohort study (COCOA).

Authors:  So-Yeon Lee; Jinho Yu; Kang-Mo Ahn; Kyung Won Kim; Youn Ho Shin; Kyung-Shin Lee; Seo Ah Hong; Young-Ho Jung; Eun Lee; Song-I Yang; Ju-Hee Seo; Ji-Won Kwon; Byoung-Ju Kim; Hyo-Bin Kim; Woo-Kyung Kim; Dae Jin Song; Gwang Cheon Jang; Jung Yeon Shim; Soo-Young Lee; Ja-Young Kwon; Suk-Joo Choi; Kyung-Ju Lee; Hee Jin Park; Hye-Sung Won; Ho-Sung Yoo; Mi-Jin Kang; Hyung-Young Kim; Soo-Jong Hong
Journal:  PLoS One       Date:  2014-05-21       Impact factor: 3.240

Review 9.  New era of biologic therapeutics in atopic dermatitis.

Authors:  Emma Guttman-Yassky; Nikhil Dhingra; Donald Y M Leung
Journal:  Expert Opin Biol Ther       Date:  2013-01-16       Impact factor: 4.388

10.  Interleukin (IL)-13 promoter polymorphisms (-7402 T/G and -4729G/A) condition susceptibility to pediatric severe malarial anemia but not circulating IL-13 levels.

Authors:  Winnie A Okeyo; Elly O Munde; Wilson Okumu; Evans Raballah; Samuel B Anyona; John M Vulule; John M Ong'echa; Douglas J Perkins; Collins Ouma
Journal:  BMC Immunol       Date:  2013-03-25       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.